Dr Madara Ratnadiwakara is a post-doctoral scientist working in the RNA Biology in Health and Disease Laboratory led by Dr Minni Änkö.
Dr Ratnadiwakara completed her PhD in 2015 at the John Curtin School of Medical Research- Australian National University under the supervision of A/Professor Anneke Blackburn. She then joined the Laboratory of Dr Minni Änkö at the Monash University in 2016 as a post-doctoral research fellow. With the relocation of the laboratory, she joined the Hudson Institute of Medical Research in 2018 with joint appointments at the Centre of Reproductive Health and Centre of Cancer Research. She also holds an adjunct appointment at the Australian Regenerative Medicine Institute.
Dr Ratnadiwakara’s current research focuses mainly on the role or RNA binding proteins in regulating RNA processing machinaries during early development and cancer.
Ratnadiwakara M, Rooke M, Ohms SJ, French HJ, Williams RBH, Li RW, Zhang D, Lucas RM and Blackburn AC (2018) The SuprMam1 breast cancer susceptibility locus disrupts the vitamin D/calcium/parathyroid hormone pathway and alters bone structure in congenic mice. The Journal of Steroid Biochemistry and Molecular Biology. Published online Dec 2018.
Ratnadiwakara M, Archer SK, Dent GI, Ruiz De Los Mozos I, Beilharz TH, Knaupp AS, Nefzger CM, Polo JM, and Änkö ML (2018) SRSF3 promotes pluripotency through Nanog mRNA export and coordination of the pluripotency gene expression program. eLife May 9; 7.
Ratnadiwakara M and Änkö ML (2018) RNA Immunoprecipitation Assay to Determine the Specificity of SRSF3 Binding to Nanog mRNA. Bio-protocol 8(21).
Ratnadiwakara M and Änkö ML (2018) mRNA Stability Assay Using Transcription Inhibition by Actinomycin D in Mouse Pluripotent Stem Cells. Bio-protocol 8(21).
Ratnadiwakara M, Mohenska M and Änkö ML (2017) Splicing factors as regulators of miRNA biogenesis – links to human disease. Seminars in Cell and Developmental Biology. Published online Nov 2017.